Kovach Eye News Today

In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is also known as nearsightedness or the need for distance vision correction.

Kovach Eye Institute in Elmhurst is the first ophthalmology practice in the state of Illinois to perform the SMILE procedure, the latest advancement in laser vision correction for myopia (near-sightedness), with or without astigmatism, providing LASIK-like outcomes.